Lipopeptide antibiotics disrupt interactions of undecaprenyl phosphate with UptA
Proceedings of the National Academy of Sciences · 2024
DOI: 10.1073/pnas.2408315121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Abraham O Oluwole und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Oxford, Oxford OX1 3QZ, United Kingdom. Hauptthemen laut MEDLINE: Bacillus subtilis, Anti-Bacterial Agents, Bacterial Proteins, Polyisoprenyl Phosphates. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Royal Society (The Royal Society), UKRI | Medical Research Council (MRC).
Abstract (Originalsprache)
The peptidoglycan pathway represents one of the most successful antibacterial targets with the last critical step being the flipping of carrier lipid, undecaprenyl phosphate (C 55 -P), across the membrane to reenter the pathway. This translocation of C 55 -P is facilitated by DedA and DUF368 domain-containing family membrane proteins via unknown mechanisms. Here, we employ native mass spectrometry to investigate the interactions of UptA, a member of the DedA family of membrane protein from Bacillus subtilis , with C 55 -P, membrane phospholipids, and cell wall-targeting antibiotics. Our results show that UptA, expressed and purified in Escherichia coli , forms monomer–dimer equilibria, and binds to C 55 -P in a pH-dependent fashion. Specifically, we show that UptA interacts more favorably with C 55 -P over shorter-chain analogs and membrane phospholipids. Moreover, we demonstrate that lipopeptide antibiotics, amphomycin and aspartocin D, can directly inhibit UptA function by out-competing the substrate for the protein binding, in addition to their propensity to form complex with free C 55 -P. Overall, this study shows that UptA-mediated translocation of C 55 -P is potentially mediated by pH and anionic phospholipids and provides insights for future development of antibiotics targeting carrier lipid recycling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Oxford, Oxford OX1 3QZ, United Kingdom.
- The Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford OX1 3QU, United Kingdom.
- Department of Chemistry and Technologies of Drug, Sapienza University of Rome, Rome 00185, Italy.
- Department of Biology, University of Oxford, Oxford OX1 3RB, United Kingdom.
ORCID-Profile: Abraham O Oluwole, Neha V Kalmankar, Michela Guida, Giovanna Poce, Jani R Bolla, Carol V Robinson
Förderung
- Wellcome Trust
- Royal Society (The Royal Society)
- UKRI | Medical Research Council (MRC)
Zitieren
APA
Oluwole, A. O., Kalmankar, N. V., Guida, M., Bennett, J. L., Poce, G., Bolla, J. R., & Robinson, C. V. (2024). Lipopeptide antibiotics disrupt interactions of undecaprenyl phosphate with UptA. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2408315121
Vancouver
Oluwole AO, Kalmankar NV, Guida M, Bennett JL, Poce G, Bolla JR, et al. Lipopeptide antibiotics disrupt interactions of undecaprenyl phosphate with UptA. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2408315121
BibTeX
@article{Oluwole2024,
author = {Oluwole, Abraham O and Kalmankar, Neha V and Guida, Michela and Bennett, Jack L and Poce, Giovanna and Bolla, Jani R and Robinson, Carol V},
title = {Lipopeptide antibiotics disrupt interactions of undecaprenyl phosphate with UptA},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
doi = {10.1073/pnas.2408315121}
}
EUVIMED